(Q35205501)

7 August 2017

1 reference

title

All-trans retinoic acid in acute promyelocytic leukaemia (English)

1 reference

7 August 2017

1 reference

1 reference

2

Martin S Tallman

1 reference

7 August 2017

Giuseppe Avvisati

1

1 reference

7 August 2017

1 September 2003

1 reference

Best Practice and Research: Clinical Haematology

7 August 2017

1 reference

7 August 2017

16

1 reference

7 August 2017

3

1 reference

7 August 2017

419-432

1 reference

Retinoids in cancer prevention and therapy

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

All-trans retinoic acid in acute promyelocytic leukemia: preliminary results in Cuba

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Tretinoin toxicity in children with acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Variability in the oral bioavailability of all-trans-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in v

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Retinoic acid resistance in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia--the occurrence of retinoic acid syndrome is a risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Extramedullary acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Two cases of extramedullary acute promyelocytic leukemia. Cytogenetics, molecular biology, and phenotypic and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900057-4

7 January 2021

10.1016/S1521-6926(03)00057-4

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12935960